<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=COX7A1</id>
	<title>COX7A1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=COX7A1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=COX7A1&amp;action=history"/>
	<updated>2026-07-04T23:41:39Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=COX7A1&amp;diff=5639&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Cytochrome c oxidase subunit 7A1, mitochondrial precursor (Cytochrome c oxidase subunit VIIa-heart) (Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase su...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=COX7A1&amp;diff=5639&amp;oldid=prev"/>
		<updated>2021-05-12T13:53:19Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Cytochrome c oxidase subunit 7A1, mitochondrial precursor (Cytochrome c oxidase subunit VIIa-heart) (Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase su...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Cytochrome c oxidase subunit 7A1, mitochondrial precursor (Cytochrome c oxidase subunit VIIa-heart) (Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase subunit VIIa-muscle) (Cytochrome c oxidase subunit VIIa-M) [COX7AH]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Age influences DNA methylation and gene expression of [[COX7A1]] in human skeletal muscle.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/18488190&lt;br /&gt;
|abstract=Reduced oxidative capacity of the mitochondria in skeletal muscle has been suggested to contribute to insulin resistance and type 2 diabetes. Moreover, a set of genes influencing oxidative phosphorylation (OXPHOS) is downregulated in diabetic muscle. Here we studied whether genetic, epigenetic and non-genetic factors influence a component of the respiratory chain, [[COX7A1]], previously shown to be downregulated in skeletal muscle from patients with type 2 diabetes. The specific aims were to: (1) evaluate the impact of genetic (single nucleotide polymorphisms [SNPs]), epigenetic (DNA methylation) and non-genetic (age) factors on the expression of [[COX7A1]] in human skeletal muscle; and (2) investigate whether common variants in the [[COX7A1]] gene are associated with increased risk of type 2 diabetes. [[COX7A1]] mRNA expression was analysed in muscle biopsies from young (n = 110) and elderly (n = 86) non-diabetic twins and related to measures of in vivo metabolism. Genetic variants (three SNPs) from the [[COX7A1]] locus were genotyped in the twins and in two independent type 2 diabetes case-control cohorts (n = 1466 and 6380, respectively). DNA methylation of the [[COX7A1]] promoter was analysed in a subset of twins (ten young, ten elderly) using bisulphite sequencing. While DNA methylation of the [[COX7A1]] promoter was increased in muscle from elderly compared with young twins (19.9  /- 8.3% vs 1.8  /- 2.7%; p = 0.035), the opposite was found for [[COX7A1]] mRNA expression (elderly 1.00  /- 0.05 vs young 1.68  /- 0.06; p = 0.0005). The heritability of [[COX7A1]] expression was estimated to be 50% in young and 72% in elderly twins. One of the polymorphisms investigated, rs753420, influenced basal [[COX7A1]] expression in muscle of young (p = 0.0001) but not of elderly twins. The transcript level of [[COX7A1]] was associated with increased in vivo glucose uptake and VO(2max) (p = 0.009 and p = 0.001, respectively). We did not observe any genetic association between [[COX7A1]] polymorphisms and type 2 diabetes after correcting for multiple testing. Our results provide further evidence for age as a factor influencing DNA methylation and expression of OXPHOS genes, and thereby in vivo metabolism.&lt;br /&gt;
|mesh-terms=* Adult&lt;br /&gt;
* Aged&lt;br /&gt;
* Aging&lt;br /&gt;
* Biopsy&lt;br /&gt;
* DNA Methylation&lt;br /&gt;
* Diabetes Mellitus, Type 2&lt;br /&gt;
* Electron Transport Complex IV&lt;br /&gt;
* Epigenesis, Genetic&lt;br /&gt;
* Female&lt;br /&gt;
* Gene Expression Regulation&lt;br /&gt;
* Genetic Predisposition to Disease&lt;br /&gt;
* Humans&lt;br /&gt;
* Insulin Resistance&lt;br /&gt;
* Male&lt;br /&gt;
* Middle Aged&lt;br /&gt;
* Muscle, Skeletal&lt;br /&gt;
* Oxidative Phosphorylation&lt;br /&gt;
* Polymorphism, Single Nucleotide&lt;br /&gt;
* Promoter Regions, Genetic&lt;br /&gt;
* RNA, Messenger&lt;br /&gt;
* Risk Factors&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1007/s00125-008-1018-8&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>